Brief: Cullinan Oncology Provides Corporate Update, Reports Q2 Results

Cullinan Therapeutics

10/08/2022 12:15

Aug 10 (Reuters) - Cullinan Oncology Inc  CGEM.O :
    * CULLINAN ONCOLOGY PROVIDES CORPORATE UPDATE AND REPORTS
SECOND
QUARTER 2022 FINANCIAL RESULTS
    * CULLINAN ONCOLOGY INC - CASH AND INVESTMENTS OF $656
MILLION1 AS
OF JUNE 30, 2022 EXPECTED TO PROVIDE RUNWAY THROUGH 2026.
    * CULLINAN ONCOLOGY - QTRLY EARNINGS PER SHARE BASIC $3.90
    * CULLINAN ONCOLOGY INC - QTRLY DILUTED EARNINGS PER SHARE
$3.77

Source text for Eikon:  ID:nGNX1s1R7G 
Further company coverage:  CGEM.O